Immunome, Inc. (IMNM)
NASDAQ: IMNM · Real-Time Price · USD
25.87
+0.05 (0.19%)
At close: Jan 23, 2026, 4:00 PM EST
25.75
-0.12 (-0.46%)
After-hours: Jan 23, 2026, 6:53 PM EST
Immunome Market Cap
Immunome has a market cap or net worth of $2.85 billion as of January 23, 2026. Its market cap has increased by 324.99% in one year.
Market Cap
2.85B
Enterprise Value
2.59B
1-Year Change
324.99%
Ranking
Category
Stock Price
$25.87
Market Cap Chart
Since the IPO on October 2, 2020, Immunome's market cap has increased from $111.39M to $2.85B, an increase of 2,462.41%. That is a compound annual growth rate of 84.15%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jan 23, 2026 | 2.85B | 20.44% |
| Dec 31, 2025 | 2.37B | 257.53% |
| Dec 31, 2024 | 662.87M | 44.98% |
| Dec 29, 2023 | 457.21M | 1,605.70% |
| Dec 30, 2022 | 26.80M | -82.91% |
| Dec 31, 2021 | 156.82M | 53.68% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Oct 2, 2020 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Erasca | 3.08B |
| Alumis | 3.06B |
| IDEAYA Biosciences | 3.05B |
| Edgewise Therapeutics | 3.03B |
| Dyne Therapeutics | 2.96B |
| Tarsus Pharmaceuticals | 2.90B |
| Catalyst Pharmaceuticals | 2.90B |
| Disc Medicine | 2.88B |